Trial Profile

Evaluation of CUR-1916 in the patients with Dravet Syndrome.

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CUR 1916 (Primary)
Indications Dravet syndrome
Focus Adverse reactions
Sponsors OPKO Health

Most Recent Events

08 Aug 2017 According to an OPKO Health media release, company plans to to file an IND for this trial and expected to begin this study by the end of 2017.
22 Mar 2017 According to an OPKO Health media release, this trial is expected to initiate in 2017.
16 Mar 2017 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com